Changhe Qi

Changhe Qi is a seasoned professional in the field of medicinal chemistry, currently serving as Senior Director at Dizal Pharmaceutical since February 2025. Prior experience includes holding the position of Vice President at TandemAI from November 2021 to January 2025, and serving as Director at Dizal Pharma from December 2017 to October 2021. Previously, Changhe Qi was a Senior Scientist at AstraZeneca between June 2015 and December 2017, and worked at Shanghai Chempartner from March 2007 to June 2015, progressing through various roles including Principal Scientist I and Senior Research Scientist. Changhe Qi earned a PhD in Organic Chemistry from the Changchun Institute of Applied Chemistry, CAS, between 2002 and 2006.